The mouse hepatitis virus A59 spike protein is not cleaved in primary hepatocyte and glial cell cultures

Advances in Experimental Medicine and Biology

Volumn 440, Issue , 1998, Pages 529-535

  Hingley, Susan T ^a   Leparc Goffart, Isabelle ^b   Weiss, Susan R ^b  

^a PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SPIKE PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL FUSION; GLIA CELL; LIVER CELL; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SYNCYTIUM; VIRUS REPLICATION;

ANIMALIA; CORONAVIRUS; MURINAE; MURINE HEPATITIS VIRUS;

EID: 0031722293     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5331-1_68     Document Type: Article

References (23)

1. Bos, E.C.W., Heijnen, L., Luytjes, W., and Spaan, W.J.M., 1995, Mutational analysis of the murine coronavirus spike protein: effect on cell-to-cell fusion, Virology 214:453-463.
2. Bosch, F. X., Garten, W., Klenk, H.-D., and Rott, R., 1981, Proteolytic cleavage of influenza virus hemagglutinins: primary structure of the connecting peptide between HA1 and HA2 determines the proteolytic cleavability and pathogenicity of avian influenza viruses, Virology 113:725-735.
3. Frana, M.F., Behnke, J.N., Sturman, S., and Holmes, K.V., 1985, Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: host-dependent differences in proteolytic cleavage and cell fusion, J. Virol. 56:912-920.
4. Gallagher, T.M., Escarmis, C., and Buchmeier, M. J., 1991, Alteration of pH dependence of coronavirus-induced cell fusion: Effect of mutations in the spike glycoprotein, J. Virol. 65:1916-1928.
5. Glickman, R.L., Syddall, R.J., Iorio, R.M., Sheehan, J.P., and Bratt, M.A., 1988, Quantitative basic residue requirements in the cleavage-activation site of the fusion glycoprotein as a determinant of virulence for Newcastle disease virus, J. Virol. 62:354-356.
6. Gombold, J.L., and Weiss, S.R., 1992, Mouse hepatitis virus A59 increases steady state levels of MHC mRNAs in primary glial cell cultures and in the murine central nervous system, Microbial Pathogenesis 13:493-505.
7. Gombold, J.L., Hingley, S.T., and Weiss, S.R., 1993, Fusion-defective mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal, J. Virol. 67:4504-4512.
8. Guo, H.-G., diMarzo Veronese, F., Tschachler, E., Pal, R., Kalyanaraman, V.S., Gallo, R.C., and Reitz, Jr., M.S., 1990, Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage, Virology 174:217-224.
9. Hingley, S.T., Gombold, J.L., Lavi, E., and Weiss, S.R., 1994, MHV-A59 fusion mutants are attenuated and display altered hepatotropism, Virology 200:1-10
10. Joseph, J., Kim, R., Siebert, K., Lublin, F.D., Offenbach, C., and Knobler, R.L., 1995, Organ specific cell heterogenicity influences differential replication and cytopathogenicity of MHV-3 and MHV-4, Adv. Exp. Med. Biol. 380:43-50.
11. Kawaoka, Y. and Webster, R.G., 1988, Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells, Proc. Natl. Acad. Sci. USA 85:324-328.
12. Klenk, H.-D. and Rott, R., 1988, The molecular biology of influenza virus pathogenicity, Adv. Vir. Res. 34:247-281.
13. Kreamer, B.L., Staecker, J.L., Sawada, N., Sattler, G.L., Hsia, M.T.S., and Pitot, H.C., 1986, Use of low-speed, iso-density percoll centrifugation method to increase the viability of isolated rat hepatocyte preparations, In Vitro Cell. Devel. Biol. 22:201-211.
14. Lavi, E., Suzumura, A., Hirayama, M., Highkin, M.K., Dambach, D.M., Silberberg, D.H., and Weiss, S.R., 1987, Coronavirus mouse hepatitis virus (MHV)-A59 causes a persistent, productive infection in primary glial cell cultures, Microbial Pathogenesis 3:79-86.
15. Lavi, E., Fishman, P.S., Highkin, M.K., and Weiss, S.R., 1988, Limbic encephalitis after inhalation of a murine coronavirus, Lab. Investig. 58:31-36.
16. Lavi, E., Murray, E.M., Makino, S., Stohlman, S.A., Lai, M.M.C., and Weiss, S.R., 1990, Determinants of coronavirus MHV pathogenesis are localized to 3′ portions of the genome as determined by ribonucleic acid-ribonucleic acid recombination, Lab. Investig. 62:570-578.
17. Martin, J.P., Chen, W., Koehren, K., Pereira, C.A., 1994, The virulence of mouse hepatitis virus 3 as evidenced by permissivity of cultured hepatic cells toward escape mutants, Res. Virol. 145:297-302.
18. McCune, J.M., Rabin, L.B., Feinberg, M.B., Leiberman, M., Kosek, J.C., Reyes, G.R., and Weissman, I.L., 1988, Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus, Cell 53:55-67.
19. Ohuchi, M., Orlich, M., Ohuchi, R., Simpson, B.E.J., Garten, W., Klenk, H.-D., and Rott, R., 1989, Mutations in the cleavage site of the hemagglutinin alter the pathogenicity of influenza virus A/Chick/Penn/83 (H5N2), Virology 168:274-280.
20. Seglen, P.O., 1976, Preparation of isolated rat liver cells, Meth. Cell Biol. 13:29-83.
21. Spaan, W.J.M., Cavanagh, D., and Horzinek, M.C., 1988, Coronaviruses. Structure and genome expression, J. Gen. Virol. 69:2939-2952.
22. Sturman, L.S., Ricardi, C.S., and Holmes, K.V., 1985, Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell fusing activity of virions by trypsin and separation of two different 90K cleavage fragments, J. Virol. 56:904-911.
23. Taguchi, F., Kawamura, S., and Fujiwara, K., 1983, Replication of mouse hepatitis viruses with high and low virulence in cultured hepatocytes, Infect. Immun. 39:955-959.